Playback speed
10 seconds
Challenges to Precision Medicine for Anti-Cancer Immunotherapy: When Other Combos w/ Anti-PD-1 Are Active, Mechanisms May Be Redundant w anti-CTLA-4
1,041 views
November 28, 2019
Login to view comments.
Click here to Login